Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gabapentin in Patients at Clinical Risk for Psychosis

NCT02557945 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT02557945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02557945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gabapentin in Patients at Clinical Risk for Psychosis
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 1/2
Overall status
Terminated
Start date
August 1, 2015
Completion date
June 12, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical high risk for psychosis